Stepping Into the Era of Combination Cancer Therapies, Part 2: Combining Targeted Therapies
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
Just before the holidays, the U.S. Food and Drug Administration (FDA) had good news for the ovarian cancer research...